IC261 is an ATP-competitive inhibitor of CK1 with IC50s about 1 μM for CK1δ and CK1ε, 16 μM for CK1α.
 
                                 
                                
                            

| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + | 
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
 
                        
                    
| 产品名称 | CK1 ↓ ↑ | CK2 ↓ ↑ | 其他靶点 | 纯度 | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PF-670462 2HCl | ++++ CK1ε, IC50: 90 nM CK1δ, IC50: 13 nM | 99%+ | |||||||||||||||||
| D4476 | ++ CK1δ, IC50: 300 nM CK1 from Schizosaccharomyces pombe, IC50: 200 nM | 99% | |||||||||||||||||
| SR-3029 | +++ CK1ε, IC50: 260 nM CK1δ, IC50: 44 nM | 99%+ | |||||||||||||||||
| IWP-2 | +++ M82FCK1δ, IC50: 40 nM | Wnt | 99% | ||||||||||||||||
| LY364947 | ++ CK1δ, IC50: 0.22 μM | 98% | |||||||||||||||||
| TA-01 | ++++ CK1ε, IC50: 6.4 nM CK1δ, IC50: 6.8 nM | p38 MAPK | 99%+ | ||||||||||||||||
| IC261 | + CK1, IC50: 16 μM | 98% | |||||||||||||||||
| PF-4800567 | +++ casein kinase 1 delta, IC50: 711 nM casein kinase 1 epsilon, IC50: 32 nM | 99%+ | |||||||||||||||||
| CK1-IN-1 | ++++ CK1ε, IC50: 16 nM CK1δ, IC50: 15 nM | 99% | |||||||||||||||||
| Longdaysin | + CKIα, IC50: 5.6 μM CKIδ, IC50: 8.8 μM | 99%+ | |||||||||||||||||
| Silmitasertib | ++++ CK2, IC50: 1 nM | 99%+ | |||||||||||||||||
| Ellagic acid (hydrate) | +++ CK2, IC50: 0.04 μM | PKA | 95+% | ||||||||||||||||
| DMAT | +++ CK2, Ki: ~40 nM | 99% | |||||||||||||||||
| Hematein | ++ CK2, IC50: 0.55 μM | 40% | |||||||||||||||||
| Silmitasertib sodium salt | ++++ CK2α, IC50: 1 nM CK2α', IC50: 1 nM | 99%+ | |||||||||||||||||
| LY294002 | +++ CK2, IC50: 98 nM | 99%+ | |||||||||||||||||
| A-3 HCl | + CK1, Ki: 80 μM | ++ CK2, Ki: 5.1 μM | MLCK,PKA,PKC | 98+% | |||||||||||||||
| TBB | + CK1, Ki: 47 μM | ++ CK2, Ki: 0.4 μM | 98% | ||||||||||||||||
| TTP 22 | ++ CK2, IC50: 100 nM | 98%+ | |||||||||||||||||
| DRB | ✔ | 99%+ | |||||||||||||||||
| BioE-1115 | + CK2α, IC50: 10 μM | 99%+ | |||||||||||||||||
| (E/Z)-GO289 | ++++ CK2, IC50: 7 nM | 99%+ | |||||||||||||||||
| 1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 | |||||||||||||||||||
| 靶点 | 
 | 
| 描述 | IC261 is a novel inhibitor of CK1 for isoforms of α[5] ,δ and ε. It inhibited cytokinesis causing a transient mitotic arrest and also led to centrosome amplification causing multipolar mitosis[6]. Inhibition of CK1 α by IC261 at concentration<300μM dose-dependently reduced LRRK2 phosphorylation at S935 and S910, as well as resulted a loss of 14-3-3 binding[5]. | 
| 作用机制 | IC261 is an ATP-competitive inhibitor and form a complex with the catalytic domain of fission yeast casein kinase-1. It stabilized casein kinase-1 in a conformation midway between nucleotide substrate liganded and nonliganded conformations.[4] | 
| Dose | Mice: 30 mg/kg[4] (i.p.) | 
| Administration | i.p. | 
| 计算器 | ||||
| 存储液制备 |  | 1mg | 5mg | 10mg | 
| 1 mM 5 mM 10 mM | 3.21mL 0.64mL 0.32mL | 16.06mL 3.21mL 1.61mL | 32.12mL 6.42mL 3.21mL | |
| CAS号 | 186611-52-9 | 
| 分子式 | C18H17NO4 | 
| 分子量 | 311.33 | 
| SMILES Code | O=C1NC2=C(C=CC=C2)/C1=C\C3=C(OC)C=C(OC)C=C3OC | 
| MDL No. | MFCD00118156 | 
| 别名 | SU5607 | 
| 运输 | 蓝冰 | 
| InChI Key | JBJYTZXCZDNOJW-JLHYYAGUSA-N | 
| Pubchem ID | 5288600 | 
| 存储条件 | In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry, room temperature | 
| 溶解方案 | DMSO: 35 mg/mL(112.42 mM),注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶 
 | 
 沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1
			沪公网安备 31011702889066号
			
			沪ICP备2024050318号-1